BMS Update

BMS for long time has been reserving its cash for one medium size pharma or biopharma deal, last year during Q1-2009 it had cash reserves of $4 Billion and now Q1 2010 it has announced that it has cash reserves worth $ 10 Billion, Last year the major deal in its kitty was of Mederex and this year we have to watch which therapeutic area it is going to invest its dollars.......